Impact of the COVID-19 pandemic on recruitment to clinical research studies in rheumatology. (2022)
Attributed to:
MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/msc.1561
PubMed Identifier: 33938621
Publication URI: http://europepmc.org/abstract/MED/33938621
Type: Journal Article/Review
Volume: 20
Parent Publication: Musculoskeletal care
Issue: 1
ISSN: 1478-2189